Overall Fundamental outlook

Business Operations:

Sector: Consumer Defensive
Industry: Household & Personal Products

Emami Limited manufactures and markets personal and healthcare products in India and internationally. It provides ayurvedic antiseptic cream, prickly heat powder, doodh kesar body lotion, aloe neem lotion, vasocare herbal petroleum jelly, coconut oil, aloe vera gel, and hygiene products under the Boroplus brand; cool oil, extra thanda, gold ayurvedic oil, therapy ayurvedic body massage and stress relief oil, maxx cool talc, and cool talc under the Navratna brand; and balm, balm ultra-power, quick relief roll-on, ortho vedic oil, ointment, relief gel and spray, healthcare products, pancharishta, nityam, and kesari jivan under the Zandu brand. The company also offers radiance cream and instant radiance face wash for men under the Fair and Handsome brand; haircare products and shampoo under the Kesh King brand; balm under the Mentho Plus brand; prickly heat powder under the Dermicool brand; hair oil, shampoos, and conditioners under the Emami 7 Oils in One brand; deodorants under the HE brand; hair colors under the Emami Diamond Shine brand; talc under the Emami Golden Beauty brand; herbal fairness cream under the Emami Naturally Fair brand; toothpaste under the Ayucare brand; hair colors and oils under the Emami Gold brand; and moisturisers, lotion, soft creams, glycerine creams and oils, petroleum jelly, baby shampoos, and other skin products under the Cream21 brand. Emami Limited was founded in 1974 and is headquartered in Kolkata, India.

Revenue projections:

Revenue projections for EMAMILTD
Revenue projections for EMAMILTD

With EMAMILTD's revenue expected to be lower than the previous year, investors may become cautious. Declining revenues often negatively impact the bottom line, reducing profitability and raising concerns among investors about the company's ability to maintain strong financial performance moving forward.

Financial Ratios:

currentRatio 2.73900
forwardPE 24.32565
debtToEquity 2.45700
earningsGrowth -0.30200
revenueGrowth -0.10300
grossMargins 0.68061
operatingMargins 0.16689
trailingEps 17.28000
forwardEps 0.00000

With a current ratio of 2.739, EMAMILTD has the liquidity needed to easily service its short-term debt. The company's cash reserves and current assets are sufficient, indicating that EMAMILTD is in a strong position to meet its immediate financial obligations without difficulty.
EMAMILTD's Forward PE being in a good range indicates the stock is priced well relative to its earnings. It is not overvalued, leaving space for future growth, making it an appealing option for investors interested in long-term value appreciation.
EMAMILTD's low growth in earnings and revenue indicates that profits could shrink. This signals potential financial difficulties for the company, suggesting that its profitability might be under pressure.
EMAMILTD's negative gross and operating margins suggest the company is not generating profit from either its production process or day-to-day operations. This could signal cost overruns or difficulties in maintaining revenue levels.

Price projections:

Price projections for EMAMILTD
Price projections for EMAMILTD

EMAMILTD's price projections have been revised downward over time, reflecting a shift in sentiment among analysts. The steady decline in projections points to a more cautious outlook on the company's future performance.

Recommendation changes over time:

Recommendations trend for EMAMILTD
Recommendations trend for EMAMILTD


The recent buy bias from analysts suggests EMAMILTD is seen as a strong investment, encouraging more investors to consider it. With this favorable sentiment, EMAMILTD appears to be a reliable option for parking money, offering stability and long-term growth potential in the stock market.